
Oncobox is a diagnostics company focused on personalized cancer therapy selection through advanced molecular profiling. Their flagship product, Oncobox Dx, utilizes comprehensive genomic profiling of tumor samples to evaluate the effectiveness of over 170 targeted and immunotherapy drugs. This tailored approach ensures that treatment plans are customized to the unique molecular characteristics of each patient's tumor, aiming to enhance the precision of cancer care. By analyzing DNA and RNA changes in tumor samples, Oncobox Dx generates a detailed report that ranks potential therapies based on…